Your browser doesn't support javascript.
loading
Investigation of endocarditis finds advanced lung adenocarcinoma: both resolve after tyrosine kinase inhibitor treatment.
Ederhy, Stéphane; Cadranel, Jacques; Granger, Camille; Hammoudi, Nadjib.
Affiliation
  • Ederhy S; Department of Cardiology, Saint-Antoine Hospital, AP-HP, Paris, France; Groupe de Recherche Clinique, Sorbonne Université, Paris, France; UNICO-GRECO Cardio-Oncology Program, Sorbonne Université, Paris, France. Electronic address: stephane.ederhy@aphp.fr.
  • Cadranel J; Department of Pulmonology and Thoracic Oncology, Assistance Publique Hopitaux de Paris, Hopital Tenon, Paris, France; Groupe de Recherche Clinique 4 (GRC 4), Theranoscan, Paris, France.
  • Granger C; Sorbonne Université, ACTION Study Group, INSERM, UMR_S 1166, Paris, France; Institute of Cardiometabolism and Nutrition (ICAN), Paris, France; Hôpital Pitié-Salpêtrière endocarditis team (AP-HP), Paris, France.
  • Hammoudi N; Sorbonne Université, ACTION Study Group, INSERM, UMR_S 1166, Paris, France; Institute of Cardiometabolism and Nutrition (ICAN), Paris, France; Hôpital Pitié-Salpêtrière endocarditis team (AP-HP), Paris, France.
Lancet ; 403(10429): 860-861, 2024 03 02.
Article in En | MEDLINE | ID: mdl-38431352

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Endocarditis / Adenocarcinoma of Lung / Lung Neoplasms Limits: Humans Language: En Journal: Lancet Year: 2024 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Endocarditis / Adenocarcinoma of Lung / Lung Neoplasms Limits: Humans Language: En Journal: Lancet Year: 2024 Type: Article